EUVIMEDEUVIMED entdecken
Crossref

Microfluidic Production of Mangiferin-Loaded Liposomes Enables Gut–Joint Axis Modulation for Early Osteoarthritis Intervention

Yiqun Ren, Bing Wang, Bin Ran, Wenxin Li, Mian Li, Dan Liu, Jingyu Li, Luxu Yin, Jinxiang Han, Bo Liu iD, Yan Zhao

ACS Applied Materials & Interfaces · 11.11.2026 · 18 (44) · 60484-60495

DOI: 10.1021/acsami.6c14321 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 30.10.2026. Verfasst von Yiqun Ren und 10 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Sciences College (Shandong Medical Biotechnology Research Center), NHC Key Laboratory of Biotechnology Drugs, Shandong First Medical Unive…. Hauptthemen laut MEDLINE: Xanthones, Liposomes, Osteoarthritis, Knee. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, Taishan Scholar Project of Shandong Province, National Natural Science Foundation of China (NSFC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Microfluidic nanomanufacturing provides a controllable and scalable strategy for improving the oral delivery of poorly bioavailable natural compounds. Herein, mangiferin-loaded liposomes (Lip@MG) were fabricated using an in-house-developed continuous microfluidic platform integrated with a high-efficiency micromixer and evaluated as a gut–joint axis-oriented intervention for early knee osteoarthritis (KOA). Compared with the conventional batch method, microfluidic synthesis produced Lip@MG with a more uniform spherical morphology, a clearly defined bilayer structure, and a narrower particle size distribution. By adjusting the flow-rate ratio, Lip@MG with tunable particle sizes from 207.8 to 118.6 nm, reduced polydispersity, and stable negative zeta potentials of up to approximately –35 mV was obtained. In vitro, Lip@MG exhibited favorable cytocompatibility and enhanced chondrocyte viability. Transcriptomic analysis, qRT-PCR, and western blot further indicated that Lip@MG attenuated LPS-induced inflammatory responses in chondrocytes, at least partly by suppressing NF-κB signaling and inhibiting p65 phosphorylation. In an anterior cruciate ligament transection-induced KOA mouse model, oral Lip@MG administration alleviated cartilage degeneration, increased cartilage thickness from 132 to 215 μm, reduced the OARSI score from 2.5 to 1.5, increased subchondral bone mineral density by 27%, and restored colonic barrier integrity, as reflected by a 65% reduction in the colonic histopathological score. Full-length 16S rRNA gene sequencing revealed that Lip@MG reshaped KOA-associated gut dysbiosis by partially restoring the Firmicutes/Bacteroidetes balance and enriching potentially beneficial taxa. These findings demonstrate that microfluidically manufactured Lip@MG is a promising nutritional nanocarrier for microbiota-centered early KOA intervention through coordinated regulation of intestinal homeostasis and joint degeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

XanthonesLiposomesOsteoarthritis, KneeAnimalsMiceChondrocytesMicrofluidicsParticle SizeMaleHumansMice, Inbred C57BL

Stichwörter der Autor:innen

NF-κB signalinggut microbiotagut–joint axisknee osteoarthritismangiferin-loaded liposomesmicrofluidic synthesis

Substanzen

XanthonesLiposomesmangiferin

Autor:innen und Institutionen

  • Biomedical Sciences College (Shandong Medical Biotechnology Research Center), NHC Key Laboratory of Biotechnology Drugs, Shandong First Medical University (Shandong Academy of Medical Sciences), Jinan, Shandong250117, C…
  • Affiliated Heze Hospital, Shandong First Medical University (Heze Municipal Hospital), Heze, Shandong274000, China.
  • School of Science, Harbin Institute of Technology, Shenzhen, Shenzhen518055, China.
  • Department of Orthopedic Surgery, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Ji…
  • School of Nuclear Science, Energy and Power Engineering, Shandong University, Jinan, Shandong250061, China.

ORCID-Profile: Bo Liu

Förderung

  • Natural Science Foundation of Shandong Province
  • Taishan Scholar Project of Shandong Province
  • National Natural Science Foundation of China (NSFC)

Zitieren

APA

Ren, Y., Wang, B., Ran, B., Li, W., Li, M., Liu, D., Li, J., Yin, L., Han, J., Liu, B., & Zhao, Y. (2026). Microfluidic Production of Mangiferin-Loaded Liposomes Enables Gut–Joint Axis Modulation for Early Osteoarthritis Intervention. ACS Applied Materials & Interfaces, 18(44), 60484-60495. https://doi.org/10.1021/acsami.6c14321

Vancouver

Ren Y, Wang B, Ran B, Li W, Li M, Liu D, et al. Microfluidic Production of Mangiferin-Loaded Liposomes Enables Gut–Joint Axis Modulation for Early Osteoarthritis Intervention. ACS Applied Materials & Interfaces. 2026;18(44):60484-60495. doi:10.1021/acsami.6c14321

BibTeX
@article{Ren2026,
  author = {Ren, Yiqun and Wang, Bing and Ran, Bin and Li, Wenxin and Li, Mian and Liu, Dan and Li, Jingyu and Yin, Luxu and Han, Jinxiang and Liu, Bo and Zhao, Yan},
  title = {Microfluidic Production of Mangiferin-Loaded Liposomes Enables Gut–Joint Axis Modulation for Early Osteoarthritis Intervention},
  journal = {ACS Applied Materials & Interfaces},
  year = {2026},
  volume = {18},
  number = {44},
  pages = {60484--60495},
  doi = {10.1021/acsami.6c14321}
}
Kostenlos starten →